Blue Trust’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Blue Trust's NVAX Position: Q3 2026 in Review
Blue Trust held its Novavax (NVAX) position steady in Q3 2026 at 50 shares worth $541. The position accounts for ﹤0.01% of the portfolio, ranked #2276.
Blue Trust first reported a position in NVAX in Q3 2022 and has held it in 16 quarters since. The position peaked at $1K in Q3 2022. 203 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Blue Trust held 50 shares of Novavax worth $541 as of Q3 2026.
- Blue Trust left its Novavax share count unchanged in Q3 2026.
- Novavax made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2276 holding.
- Blue Trust first reported a position in Novavax in Q3 2022 and has held it in 16 quarters since.
- Blue Trust's Novavax position peaked at $1K in Q3 2022.
- 203 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.